![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC & CSCC
LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.
What is LIBTAYO® (cemiplimab-rwlc) | Advanced BCC
Learn about LIBTAYO® (cemiplimab-rwlc), a prescription medicine used to treat patients with BCC that has spread or cannot be removed with surgery, and who have previously received treatment with HHI or cannot receive treatment with HHI.
Register for LIBTAYO Surround® | LIBTAYO® (cemiplimab-rwlc)
Register and connect to a variety of patient resources for LIBTAYO® (cemiplimab-rwlc). Review Important Safety Info & Full Prescribing Information including Med Guide.
Taking LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO® (cemiplimab-rwlc) is a prescription IV infusion given for 30 minutes every 3 weeks. Review Important Safety Info & Full Prescribing Information including Med Guide.
Treatment for Advanced CSCC | LIBTAYO® (cemiplimab-rwlc)
LIBTAYO is a prescription medication used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if LIBTAYO is safe and effective in children.
What is LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO is the first medicine approved by the Food and Drug Administration (FDA) to treat CSCC that has spread or cannot be cured by surgery or radiation. LIBTAYO is a type of immunotherapy called a programmed death receptor-1 (PD-1) inhibitor. LIBTAYO is not chemotherapy or radiation therapy.
Treatment in Advanced NSCLC | LIBTAYO® (cemiplimab-rwlc)
Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced non-small cell lung cancer (NSCLC). Review Important Safety Info & Full Prescribing Information including Med Guide. FOR US RESIDENTS ONLY
LIBTAYO is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.
Patient Stories in Advanced BCC | LIBTAYO® (cemiplimab-rwlc)
Find personal stories of people living with advanced BCC, including their experiences with LIBTAYO® (cemiplimab-rwlc). Review Important Safety Info & Full Prescribing Information including Med Guide.
Patient Resources for LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
LIBTAYO patient brochure: In this brochure, you will find information about treatment with LIBTAYO and other helpful resources, including the LIBTAYO patient wallet card. LIBTAYO Surround® patient overview brochure: If you are eligible, LIBTAYO Surround may help you with financial support for LIBTAYO